Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results

- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23

FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering biosciences and diagnostics company, today filed its Form 10-Q for the third quarter ended April 30, 2023 of Fiscal Year 2023 (Q3 FY23). Enzo Biochem will not be hosting a financial webcast or call for this most recent quarterly reporting period.